Araris Biotech AG Announces Strategic Investment with Samsung Ventures
Samsung Ventures makes investment in Araris Proceeds will be used to support further development and…
Month: April 2023
InflaRx Announces Pricing of $40 Million Public Offering of Ordinary Shares
JENA, Germany, April 12, 2023 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a…
HUTCHMED Highlights Presentations at American Association for Cancer Research Annual Meeting 2023
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 11, 2023 (GLOBE NEWSWIRE) —…
Aligos Therapeutics to Present Data from Chronic Hepatitis B and Hepatocellular Carcinoma Programs at the European Association for the Study of the Liver (EASL) Congress 2023
SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
Ocugen to Host Virtual Investor & Analyst Event on April 14, 2023
Company to share preliminary safety and efficacy data from ongoing Phase 1/2 trial of OCU400…
Destiny Media Technologies Schedules Fiscal 2023 Second Quarter Earnings Release and Webinar
Vancouver, British Columbia–(Newsfile Corp. – April 11, 2023) – Destiny Media Technologies Inc. (TSXV: DSY)…
WeCommerce Shareholders Approve Business Combination with Tiny
Victoria, British Columbia–(Newsfile Corp. – April 11, 2023) – WeCommerce Holdings Ltd. (TSXV: WE) (“WeCommerce”…
DCH Shortens Integration Cycles by 70 Percent With Boomi
Hong Kong-based conglomerate strengthens service delivery through the Boomi platform, taking digital transformation to the…
CANbridge Pharmaceuticals Spinal Muscular Atrophy Gene Therapy Abstract Accepted for Presentation at the American Society for Gene and Cell Therapy annual Meeting
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (1228.HK), a China and U.S.-based global biopharmaceutical company…
Cellectis Announces Dosing of the First Patient in Europe with its In-house Manufactured Product Candidate UCART22
UCART22 is currently the most advanced allogeneic CAR T-cell product in development for relapsed or…
Elucida Oncology to Present New Clinical and Preclinical Data at the 2023 AACR Annual Meeting
MONMOUTH JUNCTION, N.J., April 11, 2023 (GLOBE NEWSWIRE) — Elucida Oncology, a clinical-stage biotechnology company…
CORRECTING and REPLACING AArete Celebrates 15 Years of Growth and Innovation
Employee-owned consulting firm’s culture of excellence drives results for clients CHICAGO–(BUSINESS WIRE)–First paragraph, first sentence…
PLx Pharma Inc. Receives Nasdaq Delisting Notice
SPARTA, N.J., April 11, 2023 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or…
Micromem Romanian Project Update
Toronto, Ontario and New York, New York–(Newsfile Corp. – April 11, 2023) – Micromem Technologies…
G2 Launches the First AI-Powered Business Software Advisor
Named “Monty,” G2’s intelligent assistant changes the way people discover software for their unique business…
Haven Energy Launches to Accelerate Consumer Adoption of Home Battery Systems, Safeguard Against Power Outages and Reduce Energy Bills
With $4.2 million in funding led by Lerer Hippeau and Giant Ventures, the seed round…
Riemer & Braunstein Announces Promotions
BOSTON–(BUSINESS WIRE)–Riemer & Braunstein LLP, a law firm concentrating on the representation of financial institutions…
Synovus Financial Corp. Releases 2022 Annual Report
COLUMBUS, Ga.–(BUSINESS WIRE)–Synovus Financial Corp. (NYSE:SNV) has released its 2022 Annual Report detailing the company’s…
CLARA Analytics to Showcase AI Innovation for Claims Management at Insurance Innovators USA 2023
CEO Heather H. Wilson Panel Presentation to Address How Technology Is Changing the Claims Process…
G1 Therapeutics to Participate in the 22nd Annual Needham Virtual Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., April 11, 2023 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…